ߜ Embolization was used to reduce the size of brain arteriovenous malformations (AVMs) prior to radiosurgical treatment in 125 patients who were poor surgical candidates or had refused surgery. Of these patients, 81% had suffered hemorrhage, and 22.4% had undergone treatment at another institution. According to the Spetzler-Martin scale, the AVMs were Grade II in 9.6%, Grade III in 31.2%, Grade IV in 30.4%, and Grades V to VI in 28.8% of the cases. Most embolizations were performed using cyanoacrylate delivered by flow-guided microcatheters. Radiosurgery was performed using a linear accelerator in 62 patients treated by the authors, and 34 patients were treated at other institutions using various methods. Embolization produced total occlusion in 11.2% of AVMs and reduced 76% of AVMs enough to allow radiosurgery. Radiosurgery produced total occlusion in 65% of the partially embolized AVMs (79% when the residual nidus was Ͻ 2 cm in diameter). Embolizations resulted in a mortality rate of 1.6% and a morbidity rate of 12.8%. No complications were associated with radiosurgery. The hemorrhage rate for partially embolized AVMs was 3% per year. No patient with a completely occluded AVM experienced rehemorrhage. Angiographic follow-up review of AVMs embolized with cyanoacrylate demonstrated a 11.8% revascularization rate, occurring within 1 year. It is concluded that after partial embolization with cyanoacrylate, the risk of hemorrhage from the residual nidus is comparable to the natural history of AVMs and that the residual nidus can be irradiated with results almost as good as for a native AVM of the same size.
LTHOUGH surgery is the gold standard for the treatment of brain arteriovenous malformations (AVMs), surgical techniques may not be suitable for some patients because of anatomical factors or poor medical condition, and alternative methods of treatment may be indicated. Radiosurgery is one alternative that has been proven safe and effective in treating small AVMs. However, radiosurgery has had a lower success rate as well as a higher complication rate when treating large AVMs. 35 , 38 Lindqvist and Steiner 31 estimated that only one-third of patients could be treated by gamma unit radiosurgery because many AVMs are too large.
Embolization of brain AVMs is another alternative. There has been important progress with this technique because of the development of new microcatheters whose progressive suppleness allows for very distal microcatheterization. Nevertheless, a perfectly controllable and permanent embolic material is still lacking. Series studying embolization of brain AVMs have reported a low rate of complete occlusion by embolization alone. Therefore embolization has been used mainly to reduce the size of the AVM before surgery, although the association of embolization and radiosurgery has seldom been reported. 1, 4, [11] [12] [13] 17, 23, 33, 36, 40, 47 Embolizing a large AVM before applying radiosurgery has three theoretical advantages: 1) it can reduce the size of the AVM so that the residual nidus can be irradiated with a better cure rate and fewer side effects; 2) it can occlude associated arterial or intranidal aneurysms to reduce the risk of bleeding while awaiting the delayed action of radiosurgery and AVM thrombosis; and 3) it can target large arteriovenous fistulas (AVFs) associated with a plexiform AVM. Such AVFs, because the mechanism of action of radiosurgery is endothelial proliferation and thrombosis, are in our opinion less sensitive to radiosurgery.
We used a combination of embolization and radiosurgery to treat 125 patients with brain AVMs. We present the results of these associated therapies.
Clinical Material and Methods

Clinical Data
Between 1985 and 1990, 125 patients with brain AVMs were treated in our institution using a protocol of embolization followed by radiosurgery. All the embolizations were performed in Lariboisière hospital. Radiosurgery was then performed in Ste. Anne-Tenon hospitals or at other institutions according to the referral pattern. Patients undergoing radiosurgery at Ste. Anne-Tenon hospitals after embolization in other institutions are not included in this series. The embolization-radiosurgery option was offered to patients for whom surgery was considered a high risk for a variety of reasons: the AVMs were too large or located in eloquent areas of the brain, the patient was in poor medical condition, or the patient had refused surgery. The AVMs that measured less than 2 cm were not included in this series because they were treated by surgery directly or radiosurgery without previous embolization.
The 125 patients included 72 males and 53 females, ranging in age from 6 to 68 years (mean 32 years). Of the 101 patients (81%) who had experienced an intracranial hemorrhage, 27 had multiple (two to four) hemorrhages. Sixty-five patients had recovered without residual deficit and in 36 a residual deficit remained. Twenty-three patients (18.5%) experienced seizures. Five patients exhibited isolated headaches, and five exhibited an isolated motor/sensory deficit.
Twenty-eight patients (22.4%) had undergone treatments at other institutions. This included the evacuation of a cerebral hematoma in six, clipping of an associated aneurysm in three, and an attempted treatment of the AVM in 19 cases (15.2%). The attempted treatments comprised: 10 partial surgical AVM removals; five radiosurgical procedures; one embolization; two combined surgery/ radiosurgery, and one embolization/radiosurgery.
Angiographic Data and Grading
All 125 patients had a true AVM with a nidus interposed between the arterial feeding vessels and draining veins; isolated direct AVFs were not included in this series. One patient had two distinct AVMs, and another with Osler-Rendu disease had two hypervascularized cortical areas that we interpreted as micro-AVMs associated with a large AVM.
The locations of the AVMs are summarized in Table 1 . Of these AVMs 108 were supratentorial and 17 involved the posterior fossa.
The sizes of the AVMs were measured on angiography. Only the size of the nidus was considered (excluding the draining veins). The maximum diameter of the nidus was between 2 and 3 cm in 13 cases, between 3 and 4 cm in 45, between 4 and 6 cm in 52, and 6 cm or more in 15 cases.
The AVMs were graded I to VI, according to the Spetzler-Martin 43 classification, which we modified by adding a Grade VI to include the AVMs judged inoperable. Grade VI was used for neurologically intact patients whose AVMs: 1) measured more than 3 cm and were located in the basal ganglia, thalamus, or brainstem; 2) involved the entire corpus callosum; and 3) extended to the cerebellar nuclei or to the cerebellar peduncles. Table 2 shows the classification of the AVMs using this grading. There were no Grade I AVMs and the mean grade was IV.
Hospitalization Protocol and Embolization Technique
Patients were admitted for a 4-to 10-day hospitalization period that included one to three embolization procedures, each separated by 3 or 4 days. Embolizations were performed with neuroleptic analgesia in most cases; general anesthesia was reserved for children and uncooperative patients. Anticoagulation therapy was not used in the first part of this study when we were using Pursil catheters (Balt Co., Montmorency, France) delivered by means of a propulsion chamber via a strictly coaxial system. Later, when using progressive suppleness catheters, we regularly used intravenous heparin therapy to obtain a prothrombin time twice that of the control. Superselective catheterizations of the AVM feeding vessels were performed using mostly flow-dependent microcatheters: Pursil microcatheters with a propulsion chamber were used before 1988; microcatheters with progressive suppleness were used after that period (Magic Catheter; Balt Co.). Superselective catheterizations with guidewire-directed microcatheters (Tracker; Target Therapeutic, Fremont, CA, or Minitorquer; Ingenor, Paris, France) were performed less often. Once the microcatheter was in place, a local amytal test was performed with 20 to 50 mg of amobarbital if superselective angiograms disclosed normal branches and when the AVM was located in an eloquent brain area. The main 
Radiosurgical Technique
Embolizations were discontinued when complete occlusion was achieved or when further embolization was judged impossible or too risky. The patients were then considered for radiosurgery. Radiosurgery using a linear accelerator was performed at our institutions in 62 cases and at other institutions in 34 cases. These other institutions were located in France or abroad and used a linear accelerator or a gamma unit.
Our multidisciplinary group (named SALT from the names of our institutions, Ste. Anne, Lariboisière, and Tenon University hospitals) began treating AVMs using radiosurgery in 1986. At that time, we were using the 18-MV x-ray minibeams of a Saturne 20 CGR linear accelerator. The beam diameter varied from 6 to 20 mm at the isocenter, by steps of 2 mm. The irradiation was performed with the patient seated in the Betti arm chair, the head secured in the Talairach stereotactic frame. 6 Eight to 13 arcs (mean 10) were used. The planification was realized using a personal computer according to the method of Betti, et al. 5 The dose was calculated and delivered at the isocenter, and one isocenter was used in most patients. The dose varied from 25 to 40 Gy according to the nidus volume and the site of the lesion and was lowered in critical or functional areas. The dose delivered at the periphery of the AVM represented 70% to 90% of the dose at the center.
In January 1990 we modified our irradiation protocol to one in which the target and the dose were chosen to deliver 25 Gy at the 60% to 70% isodose range at the periphery of the AVM (the peripheral isodose). We also developed a multiple target irradiation strategy for large AVMs using the associated targets methodology and the threedimensional treatment planning software system Artemis-3D working on a Vax station (model 3200; Digital Equipment Corp., Maynard, MA). [27] [28] [29] We included in the peripheral isodose all the nidus as well as the origin of the draining veins. We also tried to include arterial and venous aneurysms or pseudoaneurysms adjacent to the nidus. Eloquent brain areas located near the AVM were defined and additional care was taken to avoid irradiating them. A major difficulty was the irradiation of large AVMs when partial embolization had divided the AVM into multiple compartments. We have previously reported the results of radiosurgery (with or without prior embolization or another therapy) of the 46 patients treated with the first method and of the first 49 treated with the second method.
37,42
Results
Number and Timing of Procedures
Of the 101 patients with ruptured AVMs, 72 were referred within 6 months of the hemorrhage (or the last of multiple hemorrhages) and 29 were referred later (mean 3 years). In the case of posthemorrhage deficit, our policy was to wait 3 months after the rupture before performing embolizations. This allowed some degree of recovery prior to embolization. We also noticed that soon after hemorrhage, superselective catheterizations were more difficult to achieve, and we suspected that in the case of posthemorrhage deficits, amytal testing could show a false negative result.
We performed 353 embolization procedures in 125 patients (mean 2.8 per patient). Embolization could be performed in 293 (83%), and it could not be performed in 60 instances (17%) because the catheterization was not distal enough or because the amytal test was positive. In 6 patients embolization could not be performed at all. Thirty-eight patients underwent one procedure and 87 underwent two or more procedures. Embolizations were completed within 1 week in 56% of the cases, in 1 week to 1 month in 10%, 1 to 6 months in 20%, and in more than 6 months (maximum 5 years) in 14%. Embolic agents were cyanoacrylates in 285 procedures (97%), particulate agents in six (silk fiber in one, polyvinyl alcohol (PVA) in five), coils in one, and a balloon in one.
After the last embolization, radiosurgery was performed within 1 month in 25%, within 6 months in another 25%, and after 6 months or more in 50% of cases. This delay in performing radiosurgery was due to various reasons, including limited access to a radiosurgery unit at the beginning of our experience and patient referral patterns.
Angiographic Results
Angiographic results of embolization and radiosurgery are presented according to the surgical grade of the AVM in Table 3 , according to the AVM volume in Table 4 , and according to the maximum diameter of the AVM in Table 5 . Table 6 shows the rate of complete AVM occlusion according to the number of arterial feeding vessels. Fourteen AVMs (11.2%) were completely occluded by embolization. Ninety-six AVMs (76.8%) were reduced enough in size by embolization to be considered for radiosurgery. Figures 1 and 2 show examples of difficult to treat AVMs that were reduced by embolization and then successfully irradiated.
Fifteen patients were not considered for radiosurgery after embolization for several reasons. In nine patients, radiosurgery was not performed because the AVM nidus was still too large despite multiple procedures, and further embolization would have entailed unacceptable risk. Two patients died due to embolization. One patient underwent surgical removal of his AVM postembolization. Two patients refused further embolization because of related complications while the AVMs were still too large for radiosurgery. One patient declined radiosurgery. Tables 3 to 5 show that the size of the AVM, analyzed by the volume or by the maximum diameter, was the major determinant for the occlusion rate by embolization/radiotherapy. Table 7 shows the rate of complete occlusion of AVMs by radiosurgery at 2 years according to the postembolization diameter of the residual nidus.
Complications From Embolization
Complications of embolization are summarized in Table 8 . Permanent complications were seen in 16 patients (12.8%) and two patients (1.6%) died. Mild deficits were seen in seven patients (5.6%). They consisted of quadrantanopias in two, diplopia in one, increase of a monoparesis in one, mild sensory deficit in one, mild cerebellar syndrome in one, and unilateral deafness in one. Moderate deficits were seen in six patients (4.8%). They consisted of two moderate hemiparesis, one worsening of a hemiparesis, one mild aphasia, and two lateral hemianopia. Severe deficits were seen in three patients (2.4%). They consisted of one hemiparesis and aphasia, one hemiparesis due to an embolus contralateral to the AVM, and one cerebellar syndrome. Among the complications were five hemorrhages (4% of patients, 1.4% of procedures). They resulted in two transient complications, one moderate deficit and were responsible for the two embolizationrelated deaths in this series: a Grade VI patient died from rupture of an AVM-related aneurysm, and a Grade III patient died from AVM rerupture.
There were no complications due to radiosurgery in the 78 patients for whom we administered follow-up care (62 patients irradiated at our institution and 16 from other institutions).
Clinical Follow-Up Review
A clinical follow-up review was available in 115 patients; among these 12 AVMs were completely embolized and 103 were partially embolized. One-third of the patients presenting with a neurological deficit improved after embolization. However, many of these patients had been experiencing gradual improvements in their deficits prior to embolization and we suspect that the improvements represented a normal posthemorrhage recovery.
Among the 23 patients with seizures, 10 improved after embolization, six were unchanged, and seven were lost to follow-up review. None of the 12 completely embolized AVMs bled. To calculate the hemorrhage rate in the 103 partially embolized AVMs, we defined a follow-up period from the date of the first embolization to the date of the last follow-up review or of an angiogram demonstrating cure of the AVM. Ten hemorrhages occurred in 10 patients during a period of 1 week to 5 years after embolization (mean 38.8-month follow-up period). This corresponded to a postembolization bleeding rate of 3.0% per year (10 hemorrhages occurred during a total follow-up period of 3992 months in 103 patients). Five patients made a good recovery, one had a moderate deficit, one a severe deficit, and three patients died. There was no correlation between postembolization hemorrhage and the size of the residual AVM or the percentage of embolization. However, all of the patients who bled postembolization had done so before embolization, whereas no patient with an unruptured AVM bled after embolization. Ruptured AVMs (86 cases with a mean follow-up period of 39 months), had a postembolization rebleeding rate of 3.6% per year.
Angiographic Follow-Up Review
Follow-up angiograms were evaluated in 88 patients in whom angiography was performed at least 3 months after the first embolization. No revascularization was seen in 76 patients during a mean angiographic follow-up period of 40 months (3-116 months). Among the AVMs completely embolized with glue, none revascularized (12 patients with a follow-up period of 6 to 41 months, mean 21 months). Among the 88 patients with angiograms, 12 revascularizations were observed (13.6%), all occurring within the 1st year after embolization, mostly in large AVMs. Two revascularizations occurred among the three patients embolized with particles of PVA. Ten revascularizations (11.8%) occurred among the 85 patients who underwent embolization with cyanoacrylates. Analysis of the angiograms found a cause for revascularization in six cases: in four cases, the glue was deposited in the arterial feeding vessel of the AVM, without reaching the nidus, and the nidus revascularized through collateral vessels. In two cases, the AVM was almost completely occluded postembolization except for a small slow-flowing area, and an angiogram performed in the days following embolization before the patient was discharged demonstrated complete thrombosis of the AVM. However, angiography performed at 1-year follow-up review demonstrated revascularization of the part of the AVM that had sustained further postembolization thrombosis. In addition, both patients were treated with radiosurgery. In the last four patients, revascularization occurred in the embolized part of the AVM despite intranidus deposition of glue.
Discussion
The combination of embolization and radiosurgery for the treatment of brain AVMs has seldom been reported. Dawson, et al., 12 reported seven patients with large AVMs who were treated with particulate embolization and gamma unit radiosurgery; at 2-year follow-up examination, two AVMs were cured and two had a 98% reduction in the nidus. Mathis, et al., 36 reported a series of patients with AVMs larger than 10 cm 3 who were treated by particulate embolization and radiosurgery; of the 56 patients treated, 24 were included in their study and 12 were cured. Lemme-Plaghos, et al., 30 reported their results in 16 patients with high-grade AVMs who were treated with a combination of embolization and gamma unit radiosurgery. Four cures were reported. It is difficult to collect and analyze data for a large series associating embolization and radiosurgery because each treatment demands long-term angiographic follow up to prove its efficacy, embolization because of the risk of revascularization and radiosurgery because its action is delayed.
Many AVMs in this series were large and high-grade, because patients with small or low-grade AVMs were treated directly by surgery or radiosurgery without embolization. Fifteen percent of patients had been unsuccessfully treated by surgery, embolization, radiosurgery, or a combination thereof.
This series has some limitations: many patients were referred for embolization from other institutions, and after embolization their radiosurgery was performed at several other institutions. For these reasons angiographic or clinical follow-up reviews were not available for all patients. Furthermore, the treatments were administered during a time when embolization and radiosurgery were evolving. Despite these limitations, we believe that the results of this series are useful for clinicians involved in the treatment of patients with difficult cerebral AVMs. We will discuss the efficacy and complications of embolization and radiosurgery when performed in association, the risk of revascularization and hemorrhage after embolization with cyanoacrylate, the grading of AVMs, and the global efficacy of embolization/radiosurgery.
Efficacy of Preradiosurgery Embolization
Fourteen AVMs (11.2%) were cured by embolization alone. An angiographic cure was obtained mainly in the smaller AVMs and, as demonstrated in Table 6 , was closely related to the number of arterial feeding vessels. There was almost no chance for embolization alone to completely occlude an AVM with more than three feeding vessels. Only one high-grade AVM with multiple feeding vessels was cured by embolization because the angioarchitecture of the lesion was of the arteriolovenous type with many arteriovenous shunts converging into a single draining venous pouch, thereby permitting us to perform transvenous approaches with the progressive occlusion of the pouch. 22 In our series, the difficulty with preradiosurgery embolization of large AVMs was in obtaining a single, uniform residual nidus well suited for radiosurgery. Most failures of embolization (patients classified as "nonsuitable for radiosurgery") were in giant AVMs in which multiple embolizations occluded parts of the nidus and reduced the flow into the AVM without reducing its global volume. This type of partial occlusion did not facilitate radiosurgery.
However, despite these limitations, embolization was successful in 96 cases (77%) in reducing the size of the AVM nidus from a mean preembolization diameter of 3.9 cm to a mean postembolization diameter of 2.1 cm (Table  5) . Such a size reduction is very important, because all radiosurgical series with the gamma unit or a linear accelerator have reported a strong correlation between the size of the AVM and the rate of obliteration. 8, 19, 31, 34, 35, 38, 44, 45 Even a recent series demonstrating an excellent obliteration rate with no difference between the 1-to 4-cm 3 and the 4-to 10-cm 3 AVMs showed a drop in the cure rate in AVMs larger than 10 cm 3 , 19 which represented the majority of our cases. Table 8 shows the complications of embolization. There were no permanent complications for Grade II AVMs. Permanent neurological deficits were 5% for Grade III, 15% for Grade IV, and 22% for Grade V and VI AVMs. High-grade AVMs are the large lesions located in critical areas, and multiple delicate embolizations are required to diminish their size, with each embolization adding to the overall risk. It should be noted that this series reports patients treated between 1985 and 1990, which corresponds in our institution to the abandonment of the propulsion chamber and the adoption of microcatheters of progressive suppleness. Some of the complications in early cases were related to our learning curve and would probably not happen now.
Morbidity of Preradiosurgery Embolization
Occlusion of normal arteries by thrombi was a major cause of morbidity during endovascular procedures, although their frequency was reduced (but not abolished) later in this study with the systematic use of intravenous heparinization. Other complications were related to the difficulty in precisely controlling the behavior of the glue and the adjustment of its polymerization time. 7 Occlusion of a draining vein of the nidus without occlusion of the nidus itself increases pressure in the nidus and may cause a hemorrhage, as observed in one patient in our series. Occlusion of any vein draining the AVM should be avoided when embolization/radiosurgery is considered; whereas a potential role of embolization is to reduce the longterm risk of hemorrhage while awaiting the effect of radiosurgery, restriction of the venous drainage of the AVM does exactly the opposite. Rupture of a large arterial aneurysm located on an AVM feeding vessel was responsible for an early postembolization hemorrhage leading to death, and for one late hemorrhage that occurred 1 year after embolization/radiosurgery, although the AVM itself was almost occluded. An aneurysm located on the arterial feeding vessel of the AVM is subjected to a high hemody-
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Embolization and radiosurgery of arteriovenous malformations namic stress but to a low blood pressure. When the AVM is embolized, the hemodynamic stress decreases and in the long term this can lead to the disappearance of the aneurysm, 26 but in the short term the blood pressure increases 24 and this may cause the aneurysm to rupture. It is impossible to predict at present which one of these factors (the favorable but delayed reduced hemodynamic stress or the unfavorable and immediate increase in pressure) will predominate; that is why AVM-associated aneurysms are now our primary target for embolization.
25
Efficacy and Complications of Postembolization Radiosurgery
The rate of permanent deficit from radiosurgery using the gamma unit 25, 31, 34 or the linear accelerator 6,9,18 is 2% to 5%. However, there were no symptomatic complications from radiosurgery in our series. We offer three explanations. First, because embolization reduced the size of the target to be irradiated, the dose was reduced. Second, when the target of radiosurgery, that is, the residual postembolization nidus, was located inside embolized areas of the AVM, normal brain was not irradiated by a too-large radiosurgery target. Third, ischemia of peri-AVM eloquent brain areas may complicate radiosurgery as well as embolization, but because embolization was performed first it took the maximum therapeutic risk.
In our series, radiosurgery on embolized AVMs resulted in a complete occlusion rate of 65%. Our radiosurgical team had a low rate of AVM occlusion at the beginning of its experience, but this improved after we started a new irradiation methodology in 1990. 37, 42 The rate of complete occlusion was 79% for AVMs with a postembolization size less than 2 cm, and 59% for postembolization AVMs larger than 2 cm in diameter. This is slightly less favorable than the cure rates described in the literature for the linear accelerator and the gamma unit irradiation of native AVMs. 6, 9, 19, 34, 42, 45 This difference between irradiation of native AVMs and postembolization AVMs of the same size may be explained by the revascularization of embolized parts of the lesions.
Close cooperation is needed between the interventional radiologist and the radiosurgical team to delineate the radiosurgery target left by partial embolization. For example, an AVM that has been embolized too far proximally (on the arterial side only) may appear mostly occluded on the preradiosurgery angiogram. In this case a portion of the nidus not filled with acrylic could be excluded from the radiosurgery target although revascularization is likely.
Revascularization After Embolization With Cyanoacrylates
None of the AVMs that were completely embolized with cyanoacrylate were revascularized at angiographic follow-up intervals ranging from 6 to 41 months (mean 21 months) and none ruptured. This is in accordance with angiographic follow-up reviews of 15 patients whose AVMs were completely embolized with NBCA; none were revascularized at 4 to 78 months postembolization. 50 In our series, angiographic follow-up review of AVMs partially embolized with NBCA demonstrated an 11.8% revascularization rate, all evident on the 1-year follow-up angiogram. Subsequent angiograms failed to demonstrate further revascularization, and we believe that after 1 year the occlusion obtained with cyanoacrylate is stable. This opinion is shared by other authors who found no difference between the 6-month and 2-year follow-up angiograms after cyanoacrylate embolization. 3 Revascularization of a previously occluded part of the nidus may be a true revascularization of the vessels that were filled with embolic material, or may be due to the development of collateral vessels as in the case of proximal embolization. 15, 30, 41, 46, 49 Progressive thrombosis of brain AVMs after embolization may also occur. 48 However, as demonstrated in two cases in our series, delayed thrombosis might not be permanent even when resulting in complete AVM occlusion. It is important to fill the entire nidus with cyanoacrylate to avoid recanalization. In the case of proximal embolization, revascularization is predictable, and the unembolized nidus (even when secondarily occluded) should be included in the radiosurgery target.
Other embolization materials were seldom used in our series. We used mechanical devices such as balloons or coils to occlude large intranidal AVFs. We used particulate agents in rare circumstances because, in our experience, they are less permanent than cyanoacrylate, and we preferred to use the most permanent agent for preradiosurgery embolization.
Risk of Hemorrhage in Partially Embolized AVMs
Various studies of the natural history of AVMs suggest bleeding rates from 2% to 4% per year. Crawford, et al., 10 reported a bleeding incidence of 2% per year; they also found that at 10 years the risk of bleeding from previously ruptured AVMs doubled when compared with unruptured lesions. Brown, et al., 8 determined a bleeding rate of 2.2% per year for unruptured AVMs. Ondra, et al., 39 reported a bleeding rate of 4% per year for all AVMs, either ruptured or unruptured. Graf, et al., 20 found that during the 1st year posthemorrhage the rebleeding risk was 6%, whereas Crawford, et al., 10 found that the risk of hemorrhage "may have been slightly increased the first two years after diagnosis." Ondra, et al., 39 found no early rebleeding tendency and a 7.7-year interval between events.
Previous series of patients with partially embolized AVMs have found a bleeding rate roughly similar to the natural history: 4% rebleeding per year for Benati, 2 a bleeding rate "similar to the natural history of AVMs" in a 5-year study period by Fournier, et al., 16 6.7% per year for Luessenhop and Presper, 32 with a large difference between ruptured and unruptured AVMs. Multiple radiosurgery series have also reported that radiosurgery does not change the rate of rebleeding of AVMs until complete thrombosis occurs, 6, 19, 34, 45 except for one study that reported a temporary increase in the bleeding risk in partially irradiated AVMs. 9 In our series, no patient bled whose AVM was completely occluded by embolization alone or by embolization/radiotherapy. Of the patients undergoing partial embolization, no patient with an unruptured AVM bled. Patients with a ruptured AVM had a 3.6% risk of rebleeding after embolization; each hemorrhage carried a 20% morbidity rate and a 30% mortality rate. Our postem-bolization rebleeding rate is in the low range when compared with the natural history of AVMs. We had hoped to reduce the risk of hemorrhage by partial embolization. That did not happen; the risk of hemorrhage remained identical. Perhaps longer follow-up review of a larger series of patients would show some benefit, especially because our embolizations had focused on the occlusion of high-risk angioarchitectural features such as associated aneurysms and venous stenosis.
We can conclude from the present series that embolization/radiotherapy of AVMs at least did not increase the risk or the morbidity of a hemorrhage.
Grading of the AVM and Efficacy of Embolization/Radiotherapy
The Spetzler-Martin 43 grading of cerebral AVMs was proposed in 1986, and a recent prospective study showed that this grading was well correlated with the morbidity from surgery. 21 Deruty, et al., 14 suggested that this classification was also well correlated with the combined therapy of AVMs (associations of surgery, embolization, and radiosurgery). Our study shows that the Spetzler-Martin classification was well correlated with the morbidity rate of embolization, and with the efficacy of embolization/ radiosurgery (Tables 3 and 8) .
This is not surprising when considering the different criteria of this classification: the maximum diameter of the AVM (1-3 points), the presence of deep venous drainage (0 or 1), and the proximity of the AVM to eloquent brain areas (0 or 1). First, the diameter of the AVM is obviously related to embolization/radiosurgery efficacy and risk, because the larger the AVM, the more difficult it is to obtain a complete occlusion. In our series the occlusion rate dropped dramatically in the giant AVMs, larger than 50 cm 3 or 6 cm in diameter. Second, the presence of deep venous drainage implies a deep location for at least part of the nidus, which is often fed by perforating arteries that are more difficult and risky to embolize. Third, AVMs located in a functional area are more risky to embolize because although the AVM itself is extraparenchymatous, it shares its arterial feeding vessels and draining veins with adjacent brain parenchyma, and occlusion of those may have serious clinical consequences.
Management of Brain AVMs
The availability of the three techniques of surgery, radiosurgery, and embolization allows a combination of therapies that must be individualized to each patient by a multidisciplinary team. Embolization has little chance of completely occluding an AVM unless the lesion is small or has less than three feeding vessels, but embolization is useful in combined therapies to facilitate surgery or radiosurgery.
After embolization, surgery has the advantage of offering an immediate cure, thereby suppressing the risk of further hemorrhage. However, we showed that the risk of hemorrhage after partial embolization of AVMs is comparable to the natural history of the lesion. Therefore, when discussing the pros and cons of combined therapies in a particular patient, it should be remembered that the risk of rerupture during the latent phase of radiosurgery is not great, and should not weigh too heavily against radiosurgery.
Conclusions
In conclusion, this series shows that after embolization with cyanoacrylate, the residual nidus of an AVM can be irradiated with results almost as good as in a native AVM of the same size. Preradiosurgery embolization with cyanoacrylate allowed the successful irradiation of large AVMs that otherwise would not have been candidates for radiosurgery.
